🚨 Oral sessions are always a highlight at #WCLC2025!
September, 8 2025 - < 1 min read

Today, our project was part of that spotlight as I3LUNGArsela Prelaj from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano presented: “A Multimodal AI-Based Clinical Decision Support System for Predicting Immunotherapy Efficacy in Metastatic NSCLC.”
This oral marks an important milestone for our project, and we are grateful to all the colleagues and collaborators whose dedication makes every study, every paper, and every presentation possible.
Great job, Arsela Prelaj and all the team involved.
Stay tuned for more information and don’t forget to follow us on our social networks:
LinkedIn | Twitter | Instagram | Facebook
Share on: